• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING STENT SYSTEM Back to Search Results
Catalog Number S-55-100-120-P6
Device Problems Improper or Incorrect Procedure or Method (2017); Device Damaged by Another Device (2915)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 01/13/2015
Event Type  malfunction  
Event Description
It was reported that the procedure was to treat a lesion located in the moderately tortuous, mildly calcified, chronic totally occluded, proximal left superficial femoral artery.Laser atherectomy was performed prior to stenting.The supera stent system was advanced, and confirmed to release successfully.The stent was deployed; however, upon removal of the interventional sheath and during closure with a closure balloon, the supera stent became explanted.It was stated that it was possible the incorrect diameter of stent was selected for use; however, this was not confirmed.Although the stent was confirmed on angiography to be deployed successfully this may have contributed to the stent being explanted during use of a closure balloon in the access site.Another supera stent was able to be deployed successfully to complete the case.No adverse patient effects or clinically significant delay in the procedure was reported.No additional information was provided.
 
Manufacturer Narrative
(b)(4) - failure to follow steps/instructions.The device was received.Investigation is not yet complete.A follow up report will be submitted with all relevant information.
 
Manufacturer Narrative
(b)(4).Evaluation summary: only the stent was returned thereby confirming that the stent had been explanted.Based on visual analysis of the returned stent, there is no indication of a product deficiency.A review of the job traveler revealed no non-conformances that would have contributed to the reported event.A review of the historical data and a similar incident query for the reported lot was performed and revealed no other incidents reported for this lot.Based on the reviewed information, no product deficiency was identified.Per the supera instruction for use (ifu), the recommended pre-dilatation diameter for a 5.5 mm stent is greater than 5.5 mm balloon.Based on the reported information, it is likely that inadequate pre-dilatation of the lesion site resulted in the stent partially deploying in the interventional sheath and upon removal of the sheath, the stent was explanted.
 
Manufacturer Narrative
(b)(4).A cine of the procedure was returned and reviewed by an abbott clinical specialist.The reviewer concluded: reportedly, the pre-dilatation balloon was a 5.0 mm balloon, which is smaller than what is recommended in the instructions for use (ifu).The ifu recommends a pre-dilation of 5.5 mm for the 5.5 mm stent.Under pre-dilation of the vessel can negatively impact the overall deployed length of the stent.In this case the vessel was under-dilated by 0.5 mm with the interventional sheath being located close to the proximal end of the stent.It is likely that the stent, which the customer states was deployed had actually partially deployed within the interventional sheath.Post deployment, when the interventional sheath was being removed, the deployed stent was repositioned and relocated within the anatomy to the access site where it was discovered and removed.However, without clear imaging, it cannot be confirmed that the proximal edge of the stent was in fact fully deployed within the vessel.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA SELF-EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 462
Manufacturer (Section G)
WEBSTER, TX USA REG#3005325609
abbott vascular
26531 ynez rd.
temecula CA 92591 462
Manufacturer Contact
connie speck
abbott vascular
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key4485240
MDR Text Key5335424
Report Number2024168-2015-00607
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial,Followup,Followup
Report Date 01/13/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/04/2015
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/30/2015
Device Catalogue NumberS-55-100-120-P6
Device Lot Number02201060
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer01/21/2015
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/13/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/01/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
GUIDE WIRE: SUPRA CORE, SHEATH: 7F TERUMO
Patient Age78 YR
Patient Weight91
-
-